Caforio Giovanni's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Mar 23, 2022
- Accession no.
- 0000014272-22-000092
- Filed
- Mar 23, 2022
- Trade date
- Mar 21-22, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.79M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Caforio GiovanniCIK 0001533201 | Director, Officer (Board Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Common Stock, $0.10 par value | SSaleDisposed | −25,000 | $71.52 | −$1,788,000 | 581,524.33 | Direct | |
| Mar 22, 2022 | Common Stock, $0.10 par value | GGiftDisposed | −420 | $0.00 | $0 | 581,104.33 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.